Table 1.

Clinical outcome 2 years after rituximab in two kidney allografts with PGNMID

	sCr upon presentation	Uric acid upon presentation	UPCR upon presentation	sCr after 2 years of rituximab	Uric acid 2 years after rituximab	UPCR 2 years after rituximab
Case 1	2 mg/dL	3+ blood, >180 RBC/HPF and >500 protein	4.4 g/g	1.08 mg/dL	1+ blood, 7 RBC/HPF and 100 protein	0.85 g/g
Case 2	2.25 mg/dL	3+ blood, >180 RBC/HPF and >500 protein	1.5 g/g	1.2–1.5 mg/dL	1+ blood, 4 RBC/HPF and 100 protein	1.5–2 g/g